Berger Lab Publications
Read the latest papers to learn more about the research being performed in the Berger Lab.
Recent Publications
Immune checkpoint landscape of human atherosclerosis and influence of cardiometabolic factors
Nature cardiovascular research. 2024 Dec ; 3:1482-1502
PREVENT Risk Score and Use of Cardioprotective Agents in Type 2 Diabetes: An Analysis of NHANES 2013 to 2020
Journal of the American Heart Association. 2024 Nov 05; 13:e037456
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
Lancet. Diabetes & endocrinology. 2024 Oct ; 12:725-734
Cardiovascular adverse event reporting in psoriasis and psoriatic arthritis biological therapy clinical trials
International journal of women's dermatology. 2024 Oct ; 10:e172
Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial
European heart journal. 2024 Sep 29; 45:3735-3747
Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus
Arthritis research & therapy. 2024 Sep 14; 26:160
Inhibiting the P2Y12 Receptor in Megakaryocytes and Platelets Suppresses Interferon-Associated Responses
JACC. Basic to translational science. 2024 Sep ; 9:1126-1140
A Platelet Reactivity ExpreSsion Score derived from patients with peripheral artery disease predicts cardiovascular risk
Nature communications. 2024 Aug 20; 15:6902